VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
AHR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AHRAmerican Healthcare REIT, Inc.
$53.02$11.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAHRCash Flow

American Healthcare REIT, Inc. (AHR) Cash Flow Statement

10Y historyFree accessUpdated daily

Cash flow quality is improving but remains volatile, with AFFO covering dividends by 2.2x in 2026Q2, up from 1.5x in 2024Q4, yet AFFO conversion is inconsistent, as evidenced by negative AFFO in 2024Q4 and significant quarterly swings in working capital.

Income StatementBalance SheetCash FlowRatios

AHR Cash Flow Statement

Annual statement

AHR Cash Flow Statement

American Healthcare REIT, Inc. (AHR) cash flow statement — 10-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16
Cash from Operations369.03M294.44M176.09M98.53M147.77M17.91M219.16M117.45M106.81M128.1M114.36M
Operating CF Growth %173.72%67.21%78.7%-33.32%724.92%-91.83%86.59%9.96%-16.62%12.02%-
Operating CF / Revenue %14.75%13.03%8.5%5.3%9.14%1.42%18.5%9.62%9.44%12.21%11.67%
Net Income121.02M70.82M-35.6M-76.89M-73.38M-53.27M2.16M-4.96M13.3M11.22M-146.03M
Depreciation & Amortization280.08M225.2M221.64M237.3M200.6M157.38M132.95M144.14M103.31M121.42M277.67M
Stock-Based Compensation19.5M14.62M9.87M5.47M3.91M9.66M-1.19M2.96M3.24M1.2M1.82M
Other Non-Cash Items-7.41M37.06M48.86M-11.55M54.44M-2.39M10.97M24.24M8.08M16.82M-2M
Working Capital Changes-21.12M-30.32M-68.68M-55.79M-37.8M-93.47M74.19M-48.92M-21.12M-22.57M-17.09M
Cash from Investing-1.36B-1.08B-8.73M9.4M-118.58M-138.65M-147.94M-103.11M-135.77M-124.55M-352.69M
Acquisitions (Net)-283.98M-118.84M-235K-12.93M-18.57M-650K00000
Purchase of Investments00000000000
Sale of Investments46.58M0000000000
Other Investing-1.08B-835.89M83.44M122.11M-28.49M-58.31M-19.64M-10.28M-68.86M-81M-306.7M
Cash from Financing1.02B817.5M-134.74M-129.06M-42.92M94.11M-8.81M2.69M37.6M4.76M226.66M
Dividends Paid-178.53M-163.52M-120.89M-76.28M-51.12M-22.79M-27M-62.61M-59.97M-55.78M-51.68M
Common Dividends-178.53M-163.52M-120.89M-76.28M-51.12M-22.79M-27M-62.61M-59.97M-55.78M-51.68M
Debt Issuance (Net)-4M-1000K-1000K-1000K1000K1000K1000K1000K1000K1000K1000K
Share Repurchases-9.76M238K-14K-469K-20.7M-382K-23.11M-89.89M-76.58M-30.66M-20.94M
Other Financing-9.73M-4.98M-382.64M-34.72M-33.93M-29.04M-724K-17.98M-8.42M1.71M9.77M
Net Change in Cash30.11M28.45M32.52M-21.12M-13.58M-26.7M62.31M17.18M8.56M8.47M-11.81M
Exchange Rate Effect-89K62K-91K7K154K-74K-90K145K-77K149K-140K
Cash at Beginning156.88M123.3M90.78M111.91M125.49M152.19M89.88M72.7M64.14M55.68M67.49M
Cash at End191.62M151.75M123.3M90.78M111.91M125.49M152.19M89.88M72.7M64.14M55.68M
Free Cash Flow261.84M165.88M84.15M-1.26M76.25M-61.78M90.85M24.62M39.91M84.55M68.37M
FCF Growth %71.04%97.13%6799.6%-101.65%223.41%-168%269.06%-38.31%-52.8%23.66%-
FCF / Revenue %10.47%7.34%4.06%-0.07%4.71%-4.89%7.67%2.02%3.53%8.06%6.97%

Key Metrics

Growth RegimeAccelerating
ProfitabilityStable
Balance SheetAdequate
Cash FlowImproving
Top Statement Risk

Labor cost pressure on margins

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

AFFO Coverage Strengthens but Remains Thin

AFFO covered dividends by 2.2x in 2026Q2, up from 1.5x in 2024Q4, as reported in the latest financials, but the buffer remains modest given volatile quarterly AFFO.

The dividend payout ratio improved to 0.46 in 2026Q2 from 1.51 in 2024Q4, indicating a significant reduction in dividend strain. However, AFFO has been erratic, with 2024Q4 showing negative AFFO, so the recent coverage may not be sustainable. Investors should monitor whether AFFO can consistently exceed dividends by a comfortable margin, especially as the company concentrates capital in senior housing.

Capex Intensity Reflects Operating Model

Capital expenditures averaged $38.5M per quarter over the last five quarters, with maintenance capex consuming a significant portion of FFO, as per the cash flow data.

The gap between FFO and AFFO, averaging $45M per quarter, highlights substantial recurring capex for tenant improvements and leasing commissions, typical for healthcare properties. This capex intensity is higher than triple-net peers, reflecting the operating nature of AHR's senior housing assets. The elevated capex may pressure AFFO growth if not offset by revenue gains.

Working Capital Swings Signal Timing Effects

Operating cash flow exceeded net income by $88M in 2026Q2, but quarterly swings in working capital have been volatile, as shown in the cash flow statement.

The large positive OCF relative to net income suggests non-cash items like depreciation and amortization are significant, but also that working capital changes are material. For instance, 2025Q3 saw OCF of $107M despite net income of $55.9M, while 2025Q1 had negative net income but positive OCF. These swings may reflect timing of rent collections and payables, warranting attention to tenant receivable quality.

Dividend Not Fully Covered by Internal Cash

In 2024Q4, dividends exceeded AFFO by 51%, indicating reliance on external sources, but by 2026Q2, AFFO covered dividends by 2.2x, per the cash flow data.

The improvement in dividend coverage suggests reduced dependency on external funding for distributions. However, the company's growth strategy may still require external capital, as evidenced by occasional negative FCF quarters. Monitoring the use of ATM programs or debt issuance will be key to assessing balance sheet strain.

Depreciation Distorts Earnings, FFO Provides Clarity

FFO exceeded net income by $72M in 2026Q2, underscoring the large depreciation charge on real estate assets, as reported in the financial statements.

The FFO-to-net-income ratio of 3.88 in 2026Q2 highlights the significant non-cash depreciation expense, which is typical for REITs. This distortion makes GAAP net income less relevant for valuation, and investors should focus on FFO and AFFO. The magnitude of depreciation is consistent with a heavy real estate asset base, but the volatility in FFO/NI across quarters suggests other non-cash items may also be at play.

Cash Flow Quality Warrants Scrutiny

Despite positive FFO, AFFO conversion has been inconsistent, with 2024Q4 AFFO negative, suggesting potential non-cash or non-recurring items inflating FFO, as per the cash flow data.

The wide gap between FFO and AFFO, averaging $45M per quarter, may indicate that a portion of FFO is not convertible to cash due to high maintenance capex. Additionally, the negative FCF in 2025Q4 and 2024Q1 raises questions about the sustainability of distributions. Investors should investigate the composition of FFO and the nature of capex to ensure cash flow quality is not overstated.

AHR — Frequently Asked Questions

Quick answers to the most common questions about buying AHR stock.

How much cash does American Healthcare REIT, Inc. (AHR) generate from operations?

American Healthcare REIT, Inc. (AHR) generated $294.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is American Healthcare REIT, Inc.'s free cash flow?

American Healthcare REIT, Inc. (AHR) generated $165.9M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is American Healthcare REIT, Inc.'s capital expenditure (CapEx)?

American Healthcare REIT, Inc. (AHR) spent $128.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does American Healthcare REIT, Inc. distribute cash to shareholders?

In 2025, American Healthcare REIT, Inc. (AHR) returned $163.5M to shareholders via cash dividends and spent $0.2M on share repurchases. This shows the company's commitment to returning capital to its equity investors.